Nexgel, Inc. (NXGL) EBT (2018 - 2025)
Nexgel's (NXGL) quarterly EBT came in at -$928000.0 in Q4 2025, down 12.62% YoY from -$1.1 million in Q4 2024, and down 43.43% on a QoQ basis from -$647000.0 in Q3 2025.
Nexgel, Inc. (NXGL) EBT (2018 - 2025) Analysis & Trends
Nexgel (NXGL) has 8 years of EBT data on file, last reported at -$928000.0 in Q4 2025.
- Quarterly EBT fell 12.62% year-over-year to -$928000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.9 million (up 16.44% YoY) and the FY2025 annual result came in at -$2.9 million, up 16.46% from the prior year.
- EBT slipped to -$928000.0 in Q4 2025, from -$647000.0 in the prior quarter.
- In the past five years, EBT ranged from a high of -$552000.0 in Q3 2023 to a low of -$1.8 million in Q1 2022.
- A 5-year average of -$936300.0 and a median of -$825000.0 in 2021 frame the typical range for EBT.
- The widest YoY moves for EBT: up 63.29% in 2022, down 160.8% in 2022.
- Tracing NXGL's EBT over 5 years: stood at -$1.8 million in 2021, then jumped by 63.29% to -$648000.0 in 2022, then slumped by 83.18% to -$1.2 million in 2023, then surged by 30.58% to -$824000.0 in 2024, then fell by 12.62% to -$928000.0 in 2025.
- The last three EBT figures came in at -$928000.0 (Q4 2025), -$647000.0 (Q3 2025), and -$640000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -928,000.00 |
| Sep 30, 2025 | -647,000.00 |
| Jun 30, 2025 | -640,000.00 |
| Mar 31, 2025 | -678,000.00 |
| Dec 31, 2024 | -824,000.00 |
| Sep 30, 2024 | -754,000.00 |
| Jun 30, 2024 | -979,000.00 |
| Mar 31, 2024 | -905,000.00 |
| Dec 31, 2023 | -1.19 Mn |
| Sep 30, 2023 | -552,000.00 |
| Jun 30, 2023 | -642,000.00 |
| Mar 31, 2023 | -807,000.00 |
| Dec 31, 2022 | -648,000.00 |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -1.04 Mn |
| Mar 31, 2022 | -1.84 Mn |
| Dec 31, 2021 | -1.77 Mn |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -826,000.00 |
| Mar 31, 2021 | -704,000.00 |